JPMorgan Healthcare Leaders ETF
J.P. Morgan Exchange-Traded Fund Trust
+61
New
61
Positions
| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | 532457108 | Apr 2024 | 845 | $660K | 9.38% | EC |
| 2 | UnitedHealth Group, Inc. | 91324P102 | Apr 2024 | 1,126 | $545K | 7.74% | EC |
| 3 | Novo Nordisk A/S | N/A | Apr 2024 | 3,176 | $407K | 5.79% | EC |
| 4 | AstraZeneca plc | N/A | Apr 2024 | 2,309 | $349K | 4.96% | EC |
| 5 | AbbVie, Inc. | 00287Y109 | Apr 2024 | 1,988 | $323K | 4.59% | EC |
| 6 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Apr 2024 | 348 | $310K | 4.40% | EC |
| 7 | Danaher Corp. | 235851102 | Apr 2024 | 962 | $237K | 3.37% | EC |
| 8 | Cigna Group (The) | 125523100 | Apr 2024 | 579 | $207K | 2.94% | EC |
| 9 | Johnson & Johnson | 478160104 | Apr 2024 | 1,398 | $202K | 2.87% | EC |
| 10 | Stryker Corp. | 863667101 | Apr 2024 | 573 | $193K | 2.74% | EC |
| 11 | Sanofi SA | N/A | Apr 2024 | 1,908 | $188K | 2.68% | EC |
| 12 | Boston Scientific Corp. | 101137107 | Apr 2024 | 2,463 | $177K | 2.52% | EC |
| 13 | HCA Healthcare, Inc. | 40412C101 | Apr 2024 | 510 | $158K | 2.25% | EC |
| 14 | Becton Dickinson & Co. | 075887109 | Apr 2024 | 638 | $150K | 2.13% | EC |
| 15 | Thermo Fisher Scientific, Inc. | 883556102 | Apr 2024 | 260 | $148K | 2.10% | EC |
| 16 | Merck & Co., Inc. | 58933Y105 | Apr 2024 | 1,143 | $148K | 2.10% | EC |
| 17 | GSK plc | N/A | Apr 2024 | 6,693 | $139K | 1.97% | EC |
| 18 | McKesson Corp. | 58155Q103 | Apr 2024 | 241 | $129K | 1.84% | EC |
| 19 | Edwards Lifesciences Corp. | 28176E108 | Apr 2024 | 1,517 | $128K | 1.83% | EC |
| 20 | Bristol-Myers Squibb Co. | 110122108 | Apr 2024 | 2,825 | $124K | 1.76% | EC |
| 21 | Daiichi Sankyo Co. Ltd. | N/A | Apr 2024 | 3,300 | $111K | 1.58% | EC |
| 22 | Novartis AG | N/A | Apr 2024 | 1,044 | $101K | 1.44% | EC |
| 23 | IQVIA Holdings, Inc. | 46266C105 | Apr 2024 | 402 | $93K | 1.32% | EC |
| 24 | Intuitive Surgical, Inc. | 46120E602 | Apr 2024 | 237 | $88K | 1.25% | EC |
| 25 | Lonza Group AG | N/A | Apr 2024 | 149 | $82K | 1.17% | EC |
| 26 | Exact Sciences Corp. | 30063P105 | Apr 2024 | 1,184 | $70K | 1.00% | EC |
| 27 | Shockwave Medical, Inc. | 82489T104 | Apr 2024 | 207 | $68K | 0.97% | EC |
| 28 | Natera, Inc. | 632307104 | Apr 2024 | 715 | $66K | 0.94% | EC |
| 29 | Amgen, Inc. | 031162100 | Apr 2024 | 238 | $65K | 0.93% | EC |
| 30 | JPMorgan U.S. Government Money Market Fund | 4812C2270 | Apr 2024 | 61,610 | $62K | 0.88% | STIV |
| 31 | Abbott Laboratories | 002824100 | Apr 2024 | 574 | $61K | 0.86% | EC |
| 32 | Acadia Healthcare Co., Inc. | 00404A109 | Apr 2024 | 819 | $61K | 0.86% | EC |
| 33 | Dexcom, Inc. | 252131107 | Apr 2024 | 474 | $60K | 0.86% | EC |
| 34 | Align Technology, Inc. | 016255101 | Apr 2024 | 208 | $59K | 0.83% | EC |
| 35 | West Pharmaceutical Services, Inc. | 955306105 | Apr 2024 | 164 | $59K | 0.83% | EC |
| 36 | Evolent Health, Inc. | 30050B101 | Apr 2024 | 2,093 | $58K | 0.83% | EC |
| 37 | Argenx SE | N/A | Apr 2024 | 155 | $57K | 0.81% | EC |
| 38 | Inspire Medical Systems, Inc. | 457730109 | Apr 2024 | 234 | $57K | 0.80% | EC |
| 39 | Centene Corp. | 15135B101 | Apr 2024 | 633 | $46K | 0.66% | EC |
| 40 | Neurocrine Biosciences, Inc. | 64125C109 | Apr 2024 | 333 | $46K | 0.65% | EC |
| 41 | Sonova Holding AG | N/A | Apr 2024 | 165 | $46K | 0.65% | EC |
| 42 | Intra-Cellular Therapies, Inc. | 46116X101 | Apr 2024 | 626 | $45K | 0.64% | EC |
| 43 | Blueprint Medicines Corp. | 09627Y109 | Apr 2024 | 472 | $43K | 0.61% | EC |
| 44 | iRhythm Technologies, Inc. | 450056106 | Apr 2024 | 388 | $43K | 0.60% | EC |
| 45 | Sartorius AG | N/A | Apr 2024 | 136 | $41K | 0.58% | EC |
| 46 | Twist Bioscience Corp. | 90184D100 | Apr 2024 | 1,300 | $41K | 0.58% | EC |
| 47 | BioMarin Pharmaceutical, Inc. | 09061G101 | Apr 2024 | 459 | $37K | 0.53% | EC |
| 48 | Agios Pharmaceuticals, Inc. | 00847X104 | Apr 2024 | 1,133 | $37K | 0.52% | EC |
| 49 | Halozyme Therapeutics, Inc. | 40637H109 | Apr 2024 | 953 | $36K | 0.52% | EC |
| 50 | Sarepta Therapeutics, Inc. | 803607100 | Apr 2024 | 286 | $36K | 0.51% | EC |
| 51 | REVOLUTION Medicines, Inc. | 76155X100 | Apr 2024 | 960 | $36K | 0.51% | EC |
| 52 | Amicus Therapeutics, Inc. | 03152W109 | Apr 2024 | 3,119 | $31K | 0.44% | EC |
| 53 | Zealand Pharma A/S | N/A | Apr 2024 | 334 | $30K | 0.43% | EC |
| 54 | Apellis Pharmaceuticals, Inc. | 03753U106 | Apr 2024 | 622 | $27K | 0.39% | EC |
| 55 | Arvinas, Inc. | 04335A105 | Apr 2024 | 809 | $26K | 0.37% | EC |
| 56 | IDEXX Laboratories, Inc. | 45168D104 | Apr 2024 | 49 | $24K | 0.34% | EC |
| 57 | REGENXBIO, Inc. | 75901B107 | Apr 2024 | 1,540 | $24K | 0.34% | EC |
| 58 | Biogen, Inc. | 09062X103 | Apr 2024 | 97 | $21K | 0.30% | EC |
| 59 | Accolade, Inc. | 00437E102 | Apr 2024 | 2,554 | $19K | 0.28% | EC |
| 60 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Apr 2024 | 134 | $19K | 0.27% | EC |
| 61 | Biohaven Ltd. | N/A | Apr 2024 | 363 | $14K | 0.20% | EC |